New chances for glaucoma patients
"An elevated, fluctuating intraocular pressure is a major risk factor for glaucoma patients. EYEMATE could be the first device that enables patients to make frequent and reliable intraocular pressure measurements on their own. These independent measurements are very useful for the doctor, allowing early, tailored treatment adjustments that improve vision retention in at risk glaucoma patients. EYEMATE does not yet have a CE mark and is currently only being used by a small number of patients as part of a clinical study. If you are interested in participating, please contact us."
Prof. Hagen Thieme, Director of the ophthalmology department of the University Clinic Magdeburg and Coordinating Investigator of the clinical study